Table 1_Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and

A prospective observational cohort study conducted between November 2022 and January 2024 assessed 52 Chinese patients with ocular myasthenia gravis. Patient outcomes were evaluated at baseline and 1, 3, and 6 months post-treatment using OMGRate, MG-QOL15, and O-QMGS scales. The study, authored by Ting Tang, validated OMGRate for severity assessment and demonstrated symptom improvement and quality of life gains.

Use Cases

• Validate the OMGRate scale for severity assessment in ocular myasthenia gravis based on longitudinal patient scores.
• Analyze correlations between symptom severity (OMGRate) and quality of life (MG-QOL15) based on the described positive correlations.
• Study the impact of factors like age of onset and AChR-Ab positivity on disease severity and quality of life based on the reported statistical associations.
• Evaluate treatment efficacy over time based on the longitudinal reductions in OMGRate, MG-QOL15, and O-QMGS scores.
• Assess the consistency between clinical symptom improvement and patient-reported outcomes based on the study's conclusion.

Strengths

• Includes longitudinal data with assessments at four distinct time points (baseline, 1, 3, and 6 months).
• Validates a specific clinical assessment tool (OMGRate) for a defined population (Chinese ocular myasthenia gravis patients).
• Reports statistical findings including p-values for associations and correlations between different assessment scales.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is 21.8 KB, indicating a very limited scope and likely small number of records.

Provenance

Source

figshare

Collection Method

Prospective observational cohort study conducted via questionnaire at a hospital.

Time Range

November 2022 to January 2024

Freshness

Last updated 2026-05-22 15:17:51; freshness should be verified.

Geography

China